Compare ZENITH HEALTH with RAYMED LABS. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZENITH HEALTH vs RAYMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZENITH HEALTH RAYMED LABS ZENITH HEALTH/
RAYMED LABS
 
P/E (TTM) x 94.6 -5.4 - View Chart
P/BV x 5.4 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZENITH HEALTH   RAYMED LABS
EQUITY SHARE DATA
    ZENITH HEALTH
Mar-21
RAYMED LABS
Mar-20
ZENITH HEALTH/
RAYMED LABS
5-Yr Chart
Click to enlarge
High Rs153 532.2%   
Low Rs11 91.8%   
Sales per share (Unadj.) Rs2.60-  
Earnings per share (Unadj.) Rs0.1-0.1 -62.4%  
Cash flow per share (Unadj.) Rs0.1-0.1 -109.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs1.3-4.6 -27.4%  
Shares outstanding (eoy) m53.744.27 1,258.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.2NM-  
Avg P/E ratio x99.4-14.8 -671.6%  
P/CF ratio (eoy) x63.3-16.6 -382.0%  
Price / Book Value ratio x6.4-0.4 -1,536.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m4378 5,300.6%   
No. of employees `000NANA-   
Total wages/salary Rs m110 6,587.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1370-  
Other income Rs m50 3,538.5%   
Total revenues Rs m1420 109,230.8%   
Gross profit Rs m4-1 -569.8%  
Depreciation Rs m30 4,166.7%   
Interest Rs m00-   
Profit before tax Rs m6-1 -996.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10-   
Profit after tax Rs m4-1 -785.7%  
Gross profit margin %2.6NM- 
Effective tax rate %21.20-   
Net profit margin %3.2NM- 
BALANCE SHEET DATA
Current assets Rs m641 7,091.1%   
Current liabilities Rs m1922 85.9%   
Net working cap to sales %32.4NM- 
Current ratio x3.30 8,259.4%  
Inventory Days Days7NM- 
Debtors Days Days44,857,990NM- 
Net fixed assets Rs m212 1,234.7%   
Share capital Rs m5443 125.7%   
"Free" reserves Rs m15-63 -23.5%   
Net worth Rs m68-20 -345.0%   
Long term debt Rs m00-   
Total assets Rs m843 3,285.6%  
Interest coverage x51.7NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.60-   
Return on assets %5.3-21.7 -24.7%  
Return on equity %6.42.8 229.0%  
Return on capital %8.32.8 296.5%  
Exports to sales %0NM-  
Imports to sales %0NM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m730-   
Fx outflow Rs m10-   
Net fx Rs m720-   
CASH FLOW
From Operations Rs m-150-  
From Investments Rs m-2NA-  
From Financial Activity Rs mNANA-  
Net Cashflow Rs m-170-  

Share Holding

Indian Promoters % 28.7 28.4 101.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.4 1.0 40.6%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.3 71.6 99.5%  
Shareholders   28,995 1,428 2,030.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZENITH HEALTH With:   ALKEM LABORATORIES  VINEET LABORATORIES  ISTREET NETWORK  BDH INDUS.  SEQUENT SCIENTIFIC  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZENITH HEALTH SHARE PRICE


Dec 3, 2021 (Close)

TRACK ZENITH HEALTH

  • Track your investment in ZENITH HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ZENITH HEALTH 5-YR ANALYSIS

COMPARE ZENITH HEALTH WITH

MARKET STATS